Literature DB >> 2086596

Identification of dengue sequences by genomic amplification: rapid diagnosis of dengue virus serotypes in peripheral blood.

V Deubel1, M Laille, J P Hugnot, E Chungue, J L Guesdon, M T Drouet, S Bassot, D Chevrier.   

Abstract

Polymerase chain reaction (PCR) was developed for the in vitro amplification of dengue virus RNA via cDNA. A fraction of the N-terminus gene of the envelope protein in the four dengue serotypes was amplified using synthetic oligonucleotide primer pairs. Amplified products were cloned and used as dengue type-specific probes in gel electrophoresis and dot-blot hybridization. We detected and characterized dengue virus serotypes in blood samples by the three-step procedure DNA-PAH consisting in cDNA priming (P), DNA amplification (A) and hybridization (H) using specific non-radiolabelled probes. Our findings showed that DNA-PAH was more rapid and sensitive in the identification of the infecting serotype than the mosquito cell cultures. Moreover, the failure of cultures to detect virus particles in sera containing few copies of viral genome or anti-dengue antibodies justified the approach of DNA-PAH to the dengue identification in clinical specimens.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2086596     DOI: 10.1016/0166-0934(90)90042-e

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  26 in total

1.  Serological differentiation of infections with dengue virus serotypes 1 to 4 by using recombinant antigens.

Authors:  Diana Ludolfs; Stefan Schilling; Jan Altenschmidt; Herbert Schmitz
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

2.  Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction.

Authors:  R S Lanciotti; C H Calisher; D J Gubler; G J Chang; A V Vorndam
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

3.  Reverse transcriptase inhibits Taq polymerase activity.

Authors:  L N Sellner; R J Coelen; J S Mackenzie
Journal:  Nucleic Acids Res       Date:  1992-04-11       Impact factor: 16.971

Review 4.  Advances in dengue diagnosis.

Authors:  M G Guzmán; G Kourí
Journal:  Clin Diagn Lab Immunol       Date:  1996-11

5.  A prospective clinical study on the use of reverse transcription-polymerase chain reaction for the early diagnosis of Dengue fever.

Authors:  Kamaljit Singh; Ajit Lale; Eng Eong Ooi; Lily-Lily Chiu; Vincent T K Chow; Paul Tambyah; Evelyn S C Koay
Journal:  J Mol Diagn       Date:  2006-11       Impact factor: 5.568

6.  Dengue-virus-infected dendritic cells trigger vascular leakage through metalloproteinase overproduction.

Authors:  Natthanej Luplertlop; Natthanej Luplerdlop; Dorothée Missé; Dorothy Bray; Virginie Deleuze; Jean-Paul Gonzalez; Vijittra Leardkamolkarn; Hans Yssel; Francisco Veas
Journal:  EMBO Rep       Date:  2006-10-06       Impact factor: 8.807

7.  Direct sequencing of genomic cDNA fragments amplified by the polymerase chain reaction for molecular epidemiology of dengue-2 viruses.

Authors:  V Deubel; R M Nogueira; M T Drouet; H Zeller; J M Reynes; D Q Ha
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

8.  Typing of dengue viruses in clinical specimens and mosquitoes by single-tube multiplex reverse transcriptase PCR.

Authors:  E Harris; T G Roberts; L Smith; J Selle; L D Kramer; S Valle; E Sandoval; A Balmaseda
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

9.  West Nile virus epidemic in horses, Tuscany region, Italy.

Authors:  Gian Luca Autorino; Antonio Battisti; Vincent Deubel; Giancarlo Ferrari; Riccardo Forletta; Armando Giovannini; Rossella Lelli; Severine Murri; Maria Teresa Scicluna
Journal:  Emerg Infect Dis       Date:  2002-12       Impact factor: 6.883

10.  A rapid method for detection and identification of flaviviruses by polymerase chain reaction and nucleic acid hybridization.

Authors:  B Puri; E A Henchal; J Burans; K R Porter; W Nelson; D M Watts; C G Hayes
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.